April 24, 2024
1,007
18
10
2.78%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:39Now PlayingACCORDING TO A RECENT ANALYSIS BY HEALTH POLICY RESEARCH FIRM KFF, MORE THAN 3 MILLION MEDICARE BENEFICIARIES COULD NOW BE ELIGIBLE TO RECEIVE COVERAGE FOR WEGOVY, A POPULAR WEIGHT LOSS DRUG THAT HAS RECENTLY BEEN APPROVED IN THE U-S FOR HEART HEALTH. HOWEVER, SOME BENEFICIARIES MAY STILL FACE OUT OF POCKET COSTS FOR THIS EXPENSIVE DRUG, AND SOME MEDICARE PRESCRIPTION DRUG PLANS MAY NOT COVER IT UNTIL 2025. ADDITIONALLY, AS MORE PART D PLANS BEGIN TO COVER WEGOVY, IT'S ALSO WORTH NOTING MEDICARE'S BUDGET MAY ALSO BE AFFECTED.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.